| 发明名称 | Pancreatic cancer biomarker using the characteristics of pancreatic cancer stem cells, and use thereof | ||
| 摘要 | The present invention relates to a novel molecular marker for pancreatic cancer stem cells and pancreatic cancer, to a marker detection method, and to a screening method. The present invention is a marker discovered from the cell lines of pancreatic cancer, wherein the marker may detect pancreatic cancer, in particular early pancreatic cancer, through the detection of a pancreatic cancer stem cell marker. In addition, the marker of the present invention may enable an accurate diagnosis and prognosis analysis of pancreatic cancer. | ||
| 申请公布号 | US9164105(B2) | 申请公布日期 | 2015.10.20 |
| 申请号 | US201213979615 | 申请日期 | 2012.01.13 |
| 申请人 | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY | 发明人 | Song Si Young;Park Soo Been;Kim Sun A |
| 分类号 | A61K38/00;G01N33/68;G01N33/574;C12Q1/68;C12N15/113 | 主分类号 | A61K38/00 |
| 代理机构 | The PL Law Group, PLLC | 代理人 | The PL Law Group, PLLC |
| 主权项 | 1. A method for treating GLRX3 (Glutaredoxin-3)-expressing pancreatic cancer in a mammalian subject in need thereof comprising, administering to the mammalian subject a therapeutically effective amount of an inhibitor against the GLRX3 (Glutaredoxin-3) activity or expression. | ||
| 地址 | Seoul KR | ||